Revenue ₹8,646 Cr (+8.4% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Aurobindo Pharma LimitedAurobindo Pharma reported Q3 FY26 consolidated revenue of ₹8,646 crore (+8.4% YoY) and EBITDA of ₹1,773 crore (20.5%...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.